14 May 2025
LONDONMETRIC PROPERTY PLC LONDONMETRIC TRANSACTS ON £62 MILLION OF SALES LondonMetric Property Plc (“LondonMetric”) announces that it has sold £61.8 million of non core…
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) GSK plc (LSE/NYSE:…
13 May 2025
Victrex plc – Interim Results 2025 STRONG FOUNDATIONS – IMPROVEMENT ACTIONS – NAVIGATING UNCERTAINTY Strong volume growth & FY volume guidance upgraded PBT held…
TREATT PLC HALF YEAR RESULTS SIX MONTHS ENDED 31 MARCH 2025 Treatt PLC (“Treatt” or the “Group”), the manufacturer and supplier of a diverse…
9 May 2025
PROPOSED SECONDARY PLACING PSC UK Pty Ltd (the “Selling Shareholder“), a wholly owned subsidiary company of the Ardonagh Group, announces its intention to sell…
Imfinzi regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial Patients lived significantly…
RECOMMENDED CASH AND SHARE ACQUISITION OF URBAN LOGISTICS REIT PLC (“URBAN LOGISTICS”) BY LONDONMETRIC PROPERTY PLC (“LONDONMETRIC”) to be effected by means of a scheme of…
8 May 2025
Steady progress in Q3 with performance in line with expectations Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes…